|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 1455 PENNSYLVANIA AVENUE, NW |
Address2 | SUITE 925 |
City | WASHINGTON |
State | DC |
Zip Code | 20004 |
Country | USA |
3. Principal place of business (if different than line 2)
City | |
State | |
Zip Code | |
Country | |
|
5. Senate ID# 66716-12
|
||||||||
|
6. House ID# 355670000
|
TYPE OF REPORT | 8. Year | 2012 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date | |
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: Steven N. LaPierre |
Date | 10/19/2012 |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TAX
16. Specific lobbying issues
S. 17, the Medical Device and Innovation Protection Act - a bill to repeal the medical device tax
S. 262, A bill to repeal the excise tax on medical device manufacturers
H.R. 436, the Protect Medical Innovation Act - a bill to repeal the medical device tax
H.R. 734, To amend the Internal Revenue Code of 1986 to repeal the medical device tax;
H.R. 488, Save Our Medical Devices Act of 2011 - a bill to repeal the medical device tax
H.R. 942, American Research and Competitiveness Act of 2011 - a bill to extend the research credit through 2012
S. 239, the Innovate America Act, a bill to support innovation through tax credits such as research and development
S. 1866, the Agree Act which calls for an increase in the rate of the alternative simplified research tax credit and makes such credit permanent
Corporate tax reform - specifically the treatment of international earnings including the Chairman's International Tax Reform discussion draft
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Brenda |
Becker |
|
|
|
Steve |
LaPierre |
|
|
|
Michael |
Mattoon |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
Medical Device User Fee Program
Health care reform implementation and rulemaking proceedings including Accountable Care Organizations; Independent Payment Advisory Board; and comparative effectiveness research, National Coverage Decisions, Coverage with Evidence Determination
Reform of the FDA medical device regulatory system particularly to promote greater efficiency, transparency, and predictability, particularly through the 510(k) system. The following bills accomplish those goals:
H.R. 3209 - Premarket Predicability Act
H.R. 3203 - Novel Device Regulatory Relief Act
H.R. 3230 - Keeping America Competitive through Harmonization Act
H.R. 3205 - FDA Renewing Efficiency from Outside Review Management Act
H.R. 3211 - Humanitarian Device Reform Act
H.R. 3208 - Patients Come First Act
H.R. 3206 - Cultivating Scientific Experts to Foster Innovation Act
H.R. 3214 - Food and Drug Administration Mission Reform Act
H.R. 3207 - Modernizing Laboratory Test Standards for Patients Act
H.R. 3204 - Guidance Accountability and Transparency Act
H.R. 3847 - Safety of Untested and New Devices Act of 2012
H.R. 3975 - A bill to extend provisions of the Pediatric Medical Device Safety and Improvement Act of 2007
H.R. 4056 - Science and Technology Regulatory Relief Act
H.R. 5651 - Food and Drug Administration Reform Act 2012
S. 1700 - The Medical Device Regulatory Improvement Act
S. 1865 - The Patient Access to Medical Innovation Act
S. 1943 - Novel Device Regulatory Relief Act of 2011
S. 1972 - A bill to amend the Food and Drug Administration's mission
S. 1995 - A bill to enhance Food and Drug Administration oversight of medical device recalls, to provide for the conditional clearance of certain medical devices, and for other purposes.
S. 2067 - Safe, Transparent, and Efficient Medical Device Act
S. 2113 - A bill to empower the Food and Drug Administration to ensure a clear and effective pathway that will encourage innovative products to benefit patients and improve health
S. 2193 - Ensuring Safe Medical Devices for Patients
S. 3187 - A bill to amend the Federal Food, Drug, and Cosetic Act to revise and extend the user-fee programs for prescription drugs and medical devices, to establish user-fee programs for generic drugs and biosimilars, and for other purposes
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Brenda |
Becker |
|
|
|
Steve |
LaPierre |
|
|
|
Michael |
Mattoon |
|
|
|
Kristen |
Hedstrom |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code EDU
16. Specific lobbying issues
S. 758, A bill to establish a Science, Technology, Engineering, and Math (STEM) Master Teacher Corps program
S. 716, Innovation Inspiration School Grant Program Act - to promote STEM education
H.R. 3373 - STEM Education Innovation Act - to promote STEM education
H.R. 6517 - The STEM Network Act - to promote STEM education
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Michael |
Mattoon |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
Appropriations for the Food and Drug Administration, particularly the Center for Devices and Radiological Health
Appropriations for pain management awareness programs
H.R. 5973 Agriculture, Rural Development, FDA & Related Agencies Appropriations Act 2013
S. 2375 Agriculture, Rural Development, FDA & Related Agencies Appropriations Act 2013
H.J. Res. 117 - Continuing Appropriations Act - provisions related to user fees for FDA
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Steve |
LaPierre |
|
|
|
Michael |
Mattoon |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code CPI
16. Specific lobbying issues
Cybersecurity - Provisions related to setting standards for information sharing between public and private entities regarding Cyber attacks
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Brenda |
Becker |
|
|
|
Steven |
LaPierre |
|
|
|
Michael |
Mattoon |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address | |
||||||
City | |
State | |
Zip Code | |
Country | |
21. Client new principal place of business (if different than line 20)
City | |
State | |
Zip Code | |
Country | |
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
5 |
|
||||||
2 |
|
6 |
|
||||||
3 |
|
7 |
|
||||||
4 |
|
8 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 3 | 5 |
2 | 4 | 6 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 5 | 9 |
2 | 6 | 10 |
3 | 7 | 11 |
4 | 8 | 12 |